Structural and physicochemical properties of two types of bacterial cellulose (BC) produced by Komagateibacter sucrofermentans strain DSM 15973^T after 7 days through either immobilized bacteria (solid inoculum) forming BCS₇ or free bacteria (liquid inoculum) forming BCL₇, followed by a water-based purification as a chem-free alternative treatment, were investigated in this study. SEM verifies the effectiveness of the water-based purification on BC network and reveals the insufficient interfibrillar space of BCS₇ compared to BCL₇. BCL₇ was generally proved to be superior to BCS₇ regarding degree of purification, BC yield, overall higher porosity, water swell ability, and water holding capacity (WHC), exhibiting higher hydrophilicity. However, thermally resistant BCS₇ reveals a 35% residual up to 800 ºC compared to BCL₇ (15%) and prevailed in terms of water retention rate. Both water-treated BC₇ were proved to be Iα-rich cellulose type and exhibited a typical type IV(a) isotherm with an H3 type of hysteresis loop, a similar pore distribution, crystallinity index (~77%), crystallite size (~7.5 cm), same levels of moisture content (~98%) and the same poor levels of rehydration after the freeze-drying process. During BCL kinetics in 20 mL of HS medium over 7 days, K. sucrofermentans, 2D pellicle formation was observed until day 3 and then 3D. The highest WHC was obtained on day 4 (116 g water/g cellulose), while the lowest on day 1 (19 g water/g cellulose). Overall, we discussed the preparation and characterization of two different BCs water-treated for purification as an eco-friendly alternative method towards functional, and sustainable application. Graphical Abstract

Kallikrein 7 (KLK7) is a chymotrypsin-like serine protease with established roles in skin diseases like the rare Netherton syndrome, an overdesquamating and inflammatory condition, but also common atopic dermatitis, and a potential drug target for these and possibly other diseases. Nevertheless, tools to determine the active KLK7 enzyme are not available. Here, a mixed alkyl aryl phosphonate quenched activity-based probe that detects the active KLK7 was developed and evaluated in vitro. This KLK7-qABP can potentially be used to monitor KLK7 activity in vivo.

We applied a new in silico approach for using protease-substrate motifs to design a kallikrein 7 (KLK7)-specific phosphonate activity-based probe (ABP) to quantify the active KLK7 in situ. Epidermal application of the ABP-inhibitor on Spink5^−/−Klk5^−/− mice, a Netherton syndrome model, reversed disease hallmarks, providing preclinical proof-of-concept for using ABPs as theranostics.

Arsonolipids represent a class of arsenic-containing compounds with interesting biological properties either as monomers or as nanostructure forming components, such as arsonoliposomes that possess selective anticancer activity as proven by in vitro and in vivo studies. In this work, we describe, for the first time, the synthesis of novel arsono-containing lipids where the alkyl groups are connected through stable ether bonds. It is expected that this class of arsonolipids, compared with the corresponding ester linked, will have higher chemical stability. To accomplish this task, a new methodology of general application was developed, where a small arsono compound, 2-hydroxyethylarsonic acid, when protected with thiophenol, can be used in an efficient and simple way as a building block for the synthesis of arsono-containing lipids as well as other arsono-containing biomolecules. Thus, besides the above-mentioned arsonolipid, an arsono cholesterol derivative was also obtained. Both ether arsonolipid and arsono cholesterol were able to form liposomes having similar physicochemical properties and integrity to conventional arsonoliposomes. Furthermore, a preliminary in vitro anticancer potential assessment of the novel ether arsonolipid containing liposomes against human prostate cancer (PC-3) and Lewis lung carcinoma (LLC) cells showed significant activity (dose- and time-dependent), which was similar to that of the conventional arsonoliposomes (studied before). Given the fact that novel arsonolipids may be more stable compared to the ones used in conventional arsonoliposomes, the current results justify further exploitation of the novel compounds by in vitro and in vivo studies.